GHO Capital raises €2.5 billion of capital to invest for Fund IV

Global Healthcare Opportunities, or GHO Capital Partners LLP (“GHO”), the European specialist investor in global healthcare, has announced the final close of its fourth fund, GHO Capital IV LP, raising over €2.5 billion (c.$2.9 billion) of capital available to invest. 

Fund IV further diversifies GHO’s investor base, with strong support from both existing LPs as well as a significant amount of capital from c. 30 new institutional investors across Europe, North America, Asia Pacific and the Middle East.

Fund IV will continue the strategy of its predecessor funds – delivering better, faster and more accessible healthcare, through scaling innovative regional leaders into vertically-integrated platforms with diversified offerings and global reach. GHO is well-positioned to capitalise on mid-market opportunities in the rapidly-growing technical healthcare sector across BioPharma, MedTech, Advisory & Data, Life Science Tools & Diagnostics and HealthTech. 

Since closing Fund III in 2021, GHO has expanded its transatlantic footprint with 19 new hires, taking the team to over 75 professionals who provide on the ground support for its portfolio across the US and Europe. The firm has also strengthened its senior leadership with the appointment of a new Partner in 2024 alongside five new Operating Partners and Senior Advisors, who bring industry insights to support thesis-driven origination and operational value creation.

Rede Partners is exceptionally proud of its longstanding relationship with GHO, having worked closely together since GHO’s inception. Rede first partnered with the team in 2015, successfully raising the €660m debut fund, and has continued to work closely together to support GHO’s franchise development over the last decade. This included raising two successor funds in 2019 and 2021 as well as a $467m continuation vehicle in 2022. As GHO’s largest fund to date, 25% larger than its predecessor, Fund IV brings GHO’s total assets under management to c.€9 billion, making GHO the largest healthcare specialist private equity firm headquartered in Europe.